Wahed Invest’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.15M Sell
14,418
-734
-5% -$60.5K 0.15% 105
2025
Q4
$1.29M Sell
15,152
-594
-4% -$48.7K 0.17% 87
2025
Q3
$1.22M Buy
15,746
+99
+0.6% +$7.74K 0.17% 93
2025
Q2
$1.22M Buy
15,647
+430
+3% +$32.1K 0.19% 81
2025
Q1
$1.1M Sell
15,217
-245
-2% -$17.5K 0.19% 82
2024
Q4
$1.14M Buy
15,462
+945
+7% +$66.1K 0.19% 75
2024
Q3
$958K Buy
14,517
+1,308
+10% +$95K 0.17% 89
2024
Q2
$1.22M Buy
13,209
+1,520
+13% +$135K 0.24% 68
2024
Q1
$1.12M Buy
11,689
+1,584
+16% +$133K 0.25% 68
2023
Q4
$771K Buy
10,105
+618
+7% +$43K 0.22% 77
2023
Q3
$657K Buy
9,487
+928
+11% +$74.6K 0.21% 76
2023
Q2
$807K Buy
8,559
+582
+7% +$50.6K 0.28% 58
2023
Q1
$660K Buy
7,977
+88
+1% +$6.92K 0.29% 59
2022
Q4
$589K Buy
7,889
+729
+10% +$56.2K 0.31% 62
2022
Q3
$592K Buy
7,160
+552
+8% +$53.1K 0.36% 46
2022
Q2
$628K Sell
6,608
-667
-9% -$69.1K 0.39% 44
2022
Q1
$856K Sell
7,275
-128
-2% -$14.4K 0.5% 39
2021
Q4
$959K Buy
+7,403
New +$864K 0.53% 37

Other funds holding EW

Wahed Invest's EW Position: Q1 2026 in Review

Wahed Invest reduced its Edwards Lifesciences (EW) stake by 4.8% in Q1 2026, selling an estimated $60.5K and leaving 14,418 shares worth $1.15M. The position accounts for 0.15% of the portfolio, ranked #105.

Wahed Invest first reported a position in EW in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.29M in Q4 2025. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Wahed Invest held 14,418 shares of Edwards Lifesciences worth $1.15M as of Q1 2026.
  • Wahed Invest sold 734 Edwards Lifesciences shares in Q1 2026, an estimated $60.5K.
  • Edwards Lifesciences made up 0.15% of Wahed Invest's portfolio in Q1 2026, its #105 holding.
  • Wahed Invest first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 18 quarters since.
  • Wahed Invest's Edwards Lifesciences position peaked at $1.29M in Q4 2025.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Wahed Invest's 13F filing for Q1 2026, filed 13 May 2026.